-
Lantheus Holdings Inc (NASDAQ: LNTH) shares
surged 58 percent to $6.15 as the company reported strong Q2 results.
-
Freshpet Inc (NASDAQ: FRPT) shares jumped 26.9
percent to $10.48. Freshpet reported a Q2 loss of $0.10 per share on revenue of $33 million.
-
Willdan Group, Inc. (NASDAQ: WLDN) gained 25.9
percent to $12.98 after the company reported upbeat Q2 results.
-
PTC Therapeutics, Inc. (NASDAQ: PTCT) rose 21.5
percent to $7.40 as the company posted a narrower-than-expected Q2 loss.
-
Kratos Defense & Security Solutions, Inc (NASDAQ: KTOS) shares climbed 17.4 percent to $5.34 as the company reported
stronger-than-expected Q2 results.
-
OvaScience Inc (NASDAQ: OVAS) rose 16.4 percent
to $6.49 as the company posted a narrower-than-expected loss for the second quarter.
-
SPX Corporation (NYSE: SPXC) shares rose 16.3
percent to $17.69 on better-than-expected quarterly results.
-
Ashford Hospitality Trust, Inc. (NYSE: AHT) gained
16.2 percent to $6.60. The real estate investment trust posted Q2 funds from operations of $0.60 per share.
-
Applied Optoelectronics Inc (NASDAQ: AAOI) rose
15.8 percent to $14.85 as the company posted better-than-expected quarterly results and issued a strong forecast for the
current quarter.
-
Performant Financial Corp (NASDAQ: PFMT) gained
14.2 percent to $2.17 as the company posted upbeat quarterly results and raised its FY16 guidance.
-
Pacific Biosciences of California (NASDAQ: PACB)
climbed 14.1 percent to $8.84 after the company reported a narrower-than-expected quarterly loss.
-
MasTec, Inc. (NYSE: MTZ) climbed 12.8 percent to
$27.50 after the company posted better-than-expected Q2 results and raised its FY16 outlook.
-
Rackspace Hosting, Inc. (NYSE: RAX) shares gained
11.3 percent to $29.54. The Wall Street Journal reported that Rackspace is in advanced talks to be sold to a private-equity
firm and a deal could be announced as soon as this week.
-
Nu Skin Enterprises, Inc. (NYSE: NUS) shares climbed
11 percent to $59.51. Nu Skin posted in-line quarterly earnings, but sales exceeded analysts’ estimates. The company also
raised its Q3 earnings guidance.
-
Acxiom Corporation (NASDAQ: ACXM) shares gained
8.8 percent to $25.13 after the company reported better-than-expected quarterly results and raised its buyback plan by $100
million to $400 million. Acxiom reported a deal to sell Impact email unit.
-
Lions Gate Entertainment Corp. (USA) (NYSE: LGF)
gained 8.4 percent to $20.63 after the company posted upbeat quarterly results.
-
Egalet Corp (NASDAQ: EGLT) shares rose 8 percent
to $8.22 as the company announced that the FDA Advisory Committee has recommended the approval of ARYMO ER. Egalet posted a Q2
loss of $0.97 per share on revenue of $3.5 million.
-
Ubiquiti Networks Inc (NASDAQ: UBNT) rose 7.3
percent to $48.36 as the company released its Q4 results after market close on Thursday. Earnings per share came in above Wall
Street consensus expectations.
-
El Pollo LoCo Holdings Inc (NYSE: LOCO) rose 6.8
percent to $13.97. El Pollo Loco reported Q2 earnings of $0.19 per share on revenue of $97.5 million.
-
Merck & Co., Inc. (NYSE: MRK) shares gained 6.8
percent to $61.76 after Bristol-Myers Squibb Co (NYSE: BMY) reported results from the CheckMate-026 Study, stating cancer-treating Opdivo
did not meet the primary endpoint.
-
Control4 Corp (NASDAQ: CTRL) shares rose 6.8
percent to $10.16. Control4 posted better-than-expected quarterly results and issued a strong FY16 outlook.
-
Symantec Corporation (NASDAQ: SYMC) gained 5.1
percent to $22.10 as the company reported better-than-expected results for the first quarter and issued a strong revenue
forecast for the current quarter.
-
Kraft Heinz Co (NASDAQ: KHC) shares rose 5.1
percent to $89.87 as the company posted upbeat earnings for the second quarter on Thursday.
-
Priceline Group Inc (NASDAQ: PCLN) shares rose
4.9 percent to $1,426.01 as the company reported stronger-than-expected earnings for its second quarter on Thursday.
-
Organovo Holdings Inc (NYSE: ONVO) shares rose 4.6
percent to $4.53 after the company reported a narrower-than-expected quarterly loss.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.